Loading tape…Loading tape…
HCA
HCA
HCA
A legal investigation by Pomerantz Law Firm concerning HCA Healthcare, Inc. was announced via prnewswire.com. Currently, HCA Healthcare operates with a market cap of approximately 87.68 billion USD and reported annual revenue of 75.6 billion USD. The company also demonstrates an EPS of 30.70 TTM, a PE ratio of 13.52, and an FCF yield of 6.84%.
Based on prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. - HCA
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. – HCA
HCA Healthcare Is Too Healthy To Downgrade
HCA Healthcare, Inc. $HCA Stock Bought by Terra Nova Asset Management LLC
Take the Zacks Approach to Beat the Markets: HF Sinclair, Accenture & FirstCash in Focus
Top 50 High-Quality Dividend Growth Stocks For October 2026
Revenue & Net Income (5Y)
EPS & Growth (5Y)
Free Cash Flow (5Y)
Capital Returns
Operating & Net Margin (5Y)
CapEx vs. Free Cash Flow (5Y)
Capital Allocation (5Y)
R&D and SG&A Intensity (5Y)
EBITDA (5Y)
Cost of Revenue (5Y)
Market Cap (5Y)
Ask Blinx with professional market data, charts beside chat, and your portfolio context.
Default quotes are Lang & Schwarz. NASDAQ is the delayed listing price. Charts stay daily. Not investment advice.